TP53 and neoplasm: Immunohistochemistry (IHC) was performed to assess the expression of key diagnostic markers, including cyclin-dependent kinase 4 (CDK4), murine double minute 2 (MDM2), p53, smooth muscle actin (SMA), and DESMIN, in both GbPDTOs and their corresponding tumor tissues.